Borealis Biosciences

Borealis Biosciences is a biotech company focused on developing RNA medicines for kidney disease. It leverages advancements in RNA therapeutics and a deep understanding of kidney disease pathologies to address unmet medical needs. The company builds upon research from Chinook Therapeutics, utilizing a strong team and academic advisors.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $150M

Date: 22-Aug-2024

Investors: Versant Ventures, Novartis AG

Markets: Biotechnology, RNA Therapeutics, Kidney Disease, Life Science, Medical

HQ: Vancouver, British Columbia, Canada

Founded: 2024

Website: https://borealisbio.com/

LinkedIn: https://www.linkedin.com/company/borealis-biosciences-inc

Twitter:

Instagram: